Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 2
1953 3
1954 3
1955 3
1956 2
1957 7
1958 3
1960 1
1961 6
1962 9
1963 13
1964 12
1965 9
1966 15
1967 22
1968 27
1969 26
1970 34
1971 23
1972 32
1973 28
1974 26
1975 29
1976 22
1977 32
1978 43
1979 41
1980 46
1981 45
1982 60
1983 72
1984 86
1985 99
1986 115
1987 114
1988 131
1989 123
1990 119
1991 107
1992 129
1993 153
1994 155
1995 172
1996 205
1997 191
1998 229
1999 241
2000 219
2001 245
2002 218
2003 216
2004 245
2005 276
2006 326
2007 336
2008 347
2009 294
2010 354
2011 369
2012 427
2013 436
2014 497
2015 441
2016 406
2017 460
2018 467
2019 477
2020 566
2021 685
2022 654
2023 518
2024 534
2025 438
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,253 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. Among authors: inoue t. N Engl J Med. 2024 Aug 15;391(7):585-597. doi: 10.1056/NEJMoa2402614. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828946 Clinical Trial.
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Yang JC, Lee DH, Lee JS, Fan Y, de Marinis F, Iwama E, Inoue T, Rodríguez-Cid J, Zhang L, Yang CT, de la Mora Jimenez E, Zhou J, Pérol M, Lee KH, Vicente D, Ichihara E, Riely GJ, Luo Y, Chirovsky D, Pietanza MC, Bhagwati N, Lu S. Yang JC, et al. Among authors: inoue t. J Clin Oncol. 2024 Dec;42(34):4029-4039. doi: 10.1200/JCO.23.02747. Epub 2024 Aug 22. J Clin Oncol. 2024. PMID: 39173098 Free PMC article. Clinical Trial.
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
Sueta D, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K; COMMAND VTE Registry-2 Investigators. Sueta D, et al. Among authors: inoue t. Thromb Haemost. 2024 Nov;124(11):1013-1023. doi: 10.1055/a-2316-5269. Epub 2024 Apr 29. Thromb Haemost. 2024. PMID: 38684190
Stress-experienced monocytes/macrophages lose anti-inflammatory function via β2-adrenergic receptor in skin allergic inflammation.
Urakami H, Yoshikawa S, Nagao K, Miyake K, Fujita Y, Komura A, Nakashima M, Umene R, Sano S, Hu Z, Nishii E, Fujimura A, Hiyama TY, Naruse K, Karasuyama H, Inoue T, Tominaga M, Takamori K, Morizane S, Miyake S. Urakami H, et al. Among authors: inoue t. J Allergy Clin Immunol. 2025 Mar;155(3):865-879. doi: 10.1016/j.jaci.2024.10.038. Epub 2024 Nov 19. J Allergy Clin Immunol. 2025. PMID: 39566608 Free article.
Metabolite phosphatase from anhydrobiotic tardigrades.
Kato S, Deguchi K, Obana M, Fujio Y, Fukuda Y, Inoue T. Kato S, et al. Among authors: inoue t. FEBS J. 2024 Dec;291(23):5195-5213. doi: 10.1111/febs.17296. Epub 2024 Oct 17. FEBS J. 2024. PMID: 39417615 Free PMC article.
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S; Genotype to Phenotype Japan (G2P-Japan) Consortium. Kuwata T, et al. Among authors: inoue t. EBioMedicine. 2024 Dec;110:105439. doi: 10.1016/j.ebiom.2024.105439. Epub 2024 Nov 1. EBioMedicine. 2024. PMID: 39488016 Free PMC article.
Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipids.
Kuwano T, Kanno T, Tobiume M, Hirata Y, Katano H, Koga M, Nagai H, Tsutsumi T, Yoshikawa N, Yotsuyanagi H, Kutsuna S, Miyazato Y, Kinoshita-Iwamoto N, Ohmagari N, Kobayashi T, Fukushima K, Tanaka M, Imamura A, Ueda Y, Iwamura M, Takada N, Inoue T, Matano T, Kawana-Tachikawa A, Suzuki T. Kuwano T, et al. Among authors: inoue t. Sci Rep. 2024 Oct 30;14(1):26057. doi: 10.1038/s41598-024-77862-0. Sci Rep. 2024. PMID: 39472469 Free PMC article.
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
Terashima Y, Matsumoto M, Ozaki S, Nakagawa M, Nakagome S, Terasaki Y, Iida H, Mitsugi R, Kuramochi E, Okada N, Inoue T, Matsuki S, Kitagawa S, Fukuizumi A, Onda N, Takeuchi S, Miyanaga A, Kasahara K, Seike M. Terashima Y, et al. Among authors: inoue t. Front Immunol. 2024 Aug 14;15:1370972. doi: 10.3389/fimmu.2024.1370972. eCollection 2024. Front Immunol. 2024. PMID: 39206190 Free PMC article.
12,253 results
You have reached the last available page of results. Please see the User Guide for more information.